Ashley Hall is Chief Development Officer of Reneo Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Aug 23 | RPHM Reneo Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 6.2757 | 15,625 | 98.06 k | 39,600 |
28 Aug 23 | RPHM Reneo Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 1.8 | 15,625 | 28.13 k | 55,225 |
28 Aug 23 | RPHM Reneo Pharmaceuticals | Stock option Common Stock | Option exercise | Dispose M | No | No | 1.8 | 15,625 | 28.13 k | 109,375 |
9 Dec 22 | RPHM Reneo Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 1.8 | 125,000 | 225.00 k | 125,000 |